Literature DB >> 23025762

Metabolomics explained to perinatologists and pediatricians.

Luigi Atzori1, Luigi Barberini, Maria Laura Santoru, Roberto Antonucci, Vassilios Fanos.   

Abstract

Metabolomics is a new approach based on the systematic study of the full complement of low-molecular weight compounds (e.g. sugars, lipids, hormones, vitamins, secondary metabolites), both endogenous and exogenous, found within a cell, tissue, biofluid or organism. In order to avoid false expectation by using a metabolomics approach, it is important to have: (i) a properly planned design of the study based on a clear question to be answered, (ii) an appropriate knowledge of the equipments available; (iii) a proper statistical analysis and support and (iv) a validation of the results obtained. In the present short-review, these topics will be briefly described.

Entities:  

Mesh:

Year:  2012        PMID: 23025762     DOI: 10.3109/14767058.2012.714636

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  1H-NMR Urinary Metabolic Profile, A Promising Tool for the Management of Infants with Human Cytomegalovirus-Infection.

Authors:  Marie Antoinette Frick; Ignasi Barba; Marina Fenoy-Alejandre; Paula López-López; Fernando Baquero-Artigao; Paula Rodríguez-Molino; Antoni Noguera-Julian; Marta Nicolás-López; Asunción de la Fuente-Juárez; Maria Gemma Codina-Grau; Juliana Esperalba Esquerra; Ángeles Linde-Sillo; Pere Soler-Palacín
Journal:  Metabolites       Date:  2019-11-25

Review 2.  Metabolomics application in maternal-fetal medicine.

Authors:  Vassilios Fanos; Luigi Atzori; Karina Makarenko; Gian Benedetto Melis; Enrico Ferrazzi
Journal:  Biomed Res Int       Date:  2013-06-09       Impact factor: 3.411

3.  Metabolite Changes in Maternal and Fetal Plasma Following Spontaneous Labour at Term in Humans Using Untargeted Metabolomics Analysis: A Pilot Study.

Authors:  Katherine A Birchenall; Gavin I Welsh; Andrés López Bernal
Journal:  Int J Environ Res Public Health       Date:  2019-04-30       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.